Hydroxychloroquine in Giant Cell Arteritis
NCT00430807
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Giant Cell Arteritis
Interventions
DRUG:
hydroxychloroquine/placebo
Sponsor
University Hospital, Toulouse